- In March 2024, Intuitive Surgical received U.S. FDA clearance for its latest da Vinci 5 robotic-assisted surgery system, which integrates artificial intelligence and machine learning to enhance surgical precision and efficiency. The system is expected to launch commercially in 2025, with capabilities tailored for high-demand procedures such as prostatectomies and hysterectomies
- In October 2024, CMR Surgical's Versius robotic system received FDA approval for use in gallbladder removal surgeries for patients aged 22 and above. The Versius system, known for mimicking human arm movements, has already completed over 26,000 procedures globally and is being rapidly adopted in U.S. and European hospitals
- In January 2025, Intuitive Surgical reported a 25% year-over-year revenue increase in Q4 2024, reaching USD 2.4 billion, driven by an 18% rise in da Vinci robotic-assisted procedures. The company anticipates continued growth with a forecasted 13–16% increase in procedures for 2025 as demand for minimally invasive surgeries accelerates
